Multi-step pancreatic carcinogenesis and its clinical implications.
The poor prognosis of pancreatic cancer relates mainly to its delayed diagnosis. It has been repeatedly shown that earlier diagnosis of pancreatic cancer is associated with a better outcome. Molecular diagnostic methods (mainly detection of K-ras mutations in pure pancreatic or duodenal juice, on specimens obtained by percutaneous fine-needle aspirations or in stool specimens) can achieve earlier diagnosis in selected subgroups of patients, such as patients with chronic pancreatitis (especially hereditary), adults with recent onset of non-insulin-dependent diabetes mellitus and patients with some inherited disorders that predispose to the development of pancreatic cancer. There is increasing evidence that pancreatic carcinogenesis is a multi-step phenomenon. Screening procedures for precursor lesions in these selected subgroups of patients may reduce the incidence and mortality from pancreatic cancer.
Sakorafas
G H
GH
Department of Surgery, 251 Hellenic Air Force (HAF) General Hospital, Athens, Greece.
Tsiotou
A G
AG
D005784:Gene Amplification; D016147:Genes, Tumor Suppressor / Q000235:genetics; D006133:Growth Substances / Q000235:genetics; D006801:Humans; D009154:Mutation; D010190:Pancreatic Neoplasms / Q000235:genetics* / Q000473:pathology*; D011519:Proto-Oncogenes / Q000235:genetics; D017978:Receptors, Growth Factor / Q000235:genetics; D012307:Risk Factors; D015854:Up-Regulation
D006133:Growth Substances; D017978:Receptors, Growth Factor